Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Richard F. Mattern

Member

Memphis
(901) 543-5933 TEL
(901) 543-5999 FAX

Richard F. Mattern

Member

Memphis
(901) 543-5933 TEL
(901) 543-5999 FAX
Memphis
(901) 543-5933 TEL
(901) 543-5999 FAX

Richard Mattern represents both public and private companies in a variety of corporate and securities law matters, helping clients achieve goals that support their overall strategic initiatives. 

As primary corporate and securities counsel to several NYSE and NASDAQ listed companies, he has represented clients in transactions ranging from $10 million to $1.4 billion as well as securities offerings ranging from $4 million to $6 billion. He also counsels private companies on capital raising, mergers and acquisitions, and other corporate matters related to their business objectives.

Richard works within a range of industries, with a particular focus in the medical device, real estate investment trust (REIT), manufacturing and banking industries. His practice includes:

  • Mergers and acquisitions
  • Corporate governance 
  • SEC regulatory reporting and compliance
  • Corporate finance
  • Venture capital and private equity financing

Prior to joining Bass, Berry & Sims, Richard was a shareholder in the Memphis office of Baker, Donelson, Bearman, Caldwell & Berkowitz P.C.

Memberships

Tennessee Bar Association

Memphis Bar Association

American Bar Association – Business Law Section, Committee on Mergers & Acquisitions

American Health Lawyers Association (AHLA)

Junior Achievement – Board of Directors (2015-2016)

News

View More

Representative Experience

View More

Media Mentions

View More

Securities Offerings

  • Represented public medical device manufacturer in connection with a $20 million initial public offering.
  • Represented public medical device manufacturer in connection with a $4 million private note offering.
  • Represented public medical device manufacturer in connection with a $10 million private placement of common stock and warrants.
  • Represented public medical device manufacturer in connection with a $5 million private placement of common stock and warrants.
  • Represented public multi-family apartment REIT in connection with multiple continuous equity offerings of up to $1.5 billion, in the aggregate, of common stock.
  • Represented international event company in connection with $7.5 million secured credit facility.
  • Represented public multi-family apartment REIT in connection with public debt offerings of $350 million, $400 million and $400 million, respectively.
  • Represented diversified industrial company in connection with a $300 million 144A private placement of high yield senior notes. 
  • Represented international event company in connection with a $5 million private placement of senior secured notes and preferred stock.
  • Represented public national bank holding company in connection with the offering of subordinated debt and bank notes in excess of $6 billion.
  • Represented public company in two $5 million private placements of public equity.

M&A Transactions

  • Represented public medical device manufacturer in connection with a $35 million strategic acquisition.
  • Represented public medical device manufacturer in connection with a sale of a division.
  • Represented public medical device manufacturer in connection with a sale of certain intellectual property.
  • Represented public multi-family apartment REIT in connection with an $8.6 billion merger transaction on Form S-4.
  • Represented public, non-traded self-storage REIT in connection with $1.4 billion cash-out merger.
  • Represented public, non-traded office and industrial REIT in connection with a $600 million merger transaction on Form S-4.
  • Represented public luxury goods retailer on Tennessee corporate law matters in connection with cash-out merger.
  • Represented public national bank holding company in $300 million divestiture of mortgage division. 
  • Represented public national bank holding company in $450 million divestiture of credit card processing subsidiary.
  • Represented public national bank holding company in connection with an $11 million merger transaction on Form S-4.

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.